Original BioMedicals Has Signed a Tripartite Memorandum of Cooperation with Nanjing Xinbai Pharmaceutical Co., Ltd. and Jiangxi Rongchang Pharmaceutical Trade Co., Ltd. to Jointly Develop the Market for Iron Dextran Injection Products
Important News
Original BioMedicals is a specialized technology platform company for innovative drug development and pharmaceutical development services, possessing strong research capabilities and a wealth of product resources. Xinbai Pharmaceutical is a subsidiary of China Resources Pharmaceutical Group, while Rongchang Pharmaceutical is a professional pharmaceutical distributor. Adhering to the principles of win-win cooperation and joint development, the three parties will leverage their respective strengths, complement resources, and establish a long-term strategic partnership. They will collaborate extensively and deeply in areas such as the development of raw materials for iron dextran injection, product sales, and manufacturing, with the goal of achieving mutual growth.
